|
Volumn 9, Issue 1, 2002, Pages 72-77
|
Atorvastatin reduces plasma levels of factor VII activity and factor VII antigen in patients with hyperlipidemia.
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALLOANTIGEN;
ANTIGEN;
ATORVASTATIN;
BLOOD CLOTTING FACTOR 7;
FACTOR VII CLOTTING ANTIGEN;
FIBRINOGEN;
HEPTANOIC ACID DERIVATIVE;
HYPOCHOLESTEROLEMIC AGENT;
PYRROLE DERIVATIVE;
TRIACYLGLYCEROL;
AGED;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
FEMALE;
GLUCOSE BLOOD LEVEL;
HEMOSTASIS;
HUMAN;
HYPERLIPIDEMIA;
MALE;
METABOLISM;
MIDDLE AGED;
RISK FACTOR;
THROMBOSIS;
AGED;
ANTICHOLESTEREMIC AGENTS;
ANTIGENS;
BLOOD GLUCOSE;
FACTOR VII;
FEMALE;
FIBRINOGEN;
HEMOSTASIS;
HEPTANOIC ACIDS;
HUMANS;
HYPERLIPIDEMIAS;
ISOANTIGENS;
MALE;
MIDDLE AGED;
PYRROLES;
RISK FACTORS;
THROMBOSIS;
TRIGLYCERIDES;
|
EID: 0036369927
PISSN: 13403478
EISSN: None
Source Type: Journal
DOI: 10.5551/jat.9.72 Document Type: Article |
Times cited : (19)
|
References (0)
|